Biomaterials for Drug Delivery in Radiotherapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 34
Special Issue Editors
Interests: nanomedicine; phytomedicine; polymer and drug delivery; immunotherapy; cancer biology
Interests: antibody drug conjugates (ADCs); photoconjugates (APCs); photoimmunotherapeutic (PIT) application; nanomaterials
Special Issue Information
Dear Colleagues,
With the increasing use of biomaterials, along with radiation therapy, for different diseases, there is a growing interest in research in this branch of medicine. Biomaterials have the potential to improve imaging technologies as a diagnostic tool, as well as improving drug delivery that directly (for example, metallic nanoparticles) or indirectly (for example, immunoadjuvants or other therapeutic agents) enhance radiation therapy and the use of biomaterials that prevent radiation damage in healthy tissue. These materials can also play a crucial role in drug delivery, enabling the controlled release of therapeutic agents directly to the targeted areas. This not only enhances the effectiveness of radiotherapy but also helps minimize the adverse effects on surrounding healthy tissue.
Given the current surge of interest in biomaterials, we are pleased to invite you to a Special Issue of the Pharmaceutics journal dedicated to Biomaterials for Drug Delivery in Radiotherapy. This may open up pathways to provide helpful resources for a better and safer diagnostic and treatment tool.
This Special Issue aims to include manuscripts aimed at enhancing radiation using various types of biomaterials for different purposes in healthcare. Original research articles and reviews are welcome in this Special Issue. Research areas may include (but are not limited to) polymer-based biomaterials or hydrogels, lipid-based biomaterials, and other organic/inorganic biomaterials, including immunoadjuvants or other biomolecules. These biomaterials, whether naturally occurring or synthetically derived, may serve as carriers for targeted drug delivery, thereby improving therapeutic outcomes in conjunction with radiation therapy.
Original research articles and reviews are welcome in this Special Issue, and we look forward to receiving your contributions.
Dr. Sayeda Yasmin-Karim
Dr. Fleury Augustin Nsole Biteghe
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomaterials in radiation
- radiation enhancers
- hydrogel in radiation
- drug delivery in radiation with biomaterials
- biomaterial delivery for image enhancers
- biomaterial delivery to reduce irradiation-related injury
- other related to the theme of this special issue
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
